| Jane was previously Managing
Director and Global Head of Life Sciences in Dresdner Kleinwort
Wasserstein's private equity division where she built and managed
a large portfolio of investments throughout Europe and the US.
She has been investing in and analysing life science companies
for over a decade and gained a strong track record and an excellent
reputation. Before moving into venture capital, Jane was one
of the City's top-rated European biotech analysts. Earlier
in her career, Jane managed late stage clinical trials and
commercial research projects. She has a PhD in Biochemistry
from Edinburgh University.
Jane is an experienced board member and has a reputation for
adding value to growth companies. In addition, she served on
several industry committees and currently holds several expert
advisory roles. |
